FEBS Letters | |
The rapid and reversible association of phosphofructokinase with myocardial membranes during myocardial ischemia | |
Hazen, Stanley L.1  Gross, Richard W.1  Ford, David A.1  Wolf, Matthew J.1  | |
[1] Division of Bioorganic Chemistry and Molecular Pharmacology, Departments of Internal Medicine, Chemistry and Molecular Biology & Pharmacology, 660 South Euclid, Box 8020, Washington University School of Medicine, St. Louis, MO, USA | |
关键词: Phosphofructokinase; Ischemia; Phospholipase A2; Myocardium; | |
DOI : 10.1016/0014-5793(94)80418-4 | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
![]() |
【 摘 要 】
Myocardial calcium-independent phospholipase A2 (PLA2) activity is mediated by a 400 kDa catalytic complex comprised of a tetramer of phosphofructokinase (PFK) and a 40 kDa catalytic subunit [1,2]. During myocardial ischemia, calcium-independent PLA2 activity rapidly and reversibly translocates from the cytosol to a membrane-associated compartment where it has been implicated as a mediator of ischemic damage [3,4]. Herein we demonstrate that the majority of both PFK mass and activity is translocated from the cytosol to a membrane-associated compartment prior to the onset of irreversible myocytic injury and that translocated PFK is catalytically inactive while membrane-associated. Furthermore, reperfusion of ischemic myocardium, or treatment of membranes derived from ischemic myocardium with ATP results in the conversion of both PFK mass and activity from its membrane-associated state to a soluble, catalytically-competent form. Collectively, these studies demonstrate that the concomitant changes in glycolysis and phospholipid hydrolysis during early myocardial ischemia result, at least in part, from the translocation of a common regulatory polypeptide critical in both processes.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020299203ZK.pdf | 404KB | ![]() |